Your browser doesn't support javascript.
loading
Multicenter Clinical Evaluation of Vitek 2 Meropenem-Vaborbactam for Susceptibility Testing of Enterobacterales and Pseudomonas aeruginosa.
Dwivedi, Hari P; Franklin, Simone; Chandrasekaran, Sukantha; Garner, Omai; Traczewski, Maria M; Beasley, Denise; Procop, Gary W; Tuohy, Marion; Wilson, Deborah; Bala, Yohann; Pincus, David H.
  • Dwivedi HP; bioMérieux, Inc., Hazelwood, Missouri, USA.
  • Franklin S; bioMérieux, Inc., Hazelwood, Missouri, USA.
  • Chandrasekaran S; Department of Pathology and Laboratory Medicine, University of California-Los Angeles, California, USA.
  • Garner O; Department of Pathology and Laboratory Medicine, University of California-Los Angeles, California, USA.
  • Traczewski MM; Clinical Microbiology Institute, Inc., Wilsonville, Oregon, USA.
  • Beasley D; Clinical Microbiology Institute, Inc., Wilsonville, Oregon, USA.
  • Procop GW; Pathology and Laboratory Medicine Institute, Cleveland Clinicgrid.239578.2, Cleveland, Ohio, USA.
  • Tuohy M; Pathology and Laboratory Medicine Institute, Cleveland Clinicgrid.239578.2, Cleveland, Ohio, USA.
  • Wilson D; Pathology and Laboratory Medicine Institute, Cleveland Clinicgrid.239578.2, Cleveland, Ohio, USA.
  • Bala Y; bioMérieux SA, Marcy l'Etoile, France.
  • Pincus DH; bioMérieux, Inc., Hazelwood, Missouri, USA.
J Clin Microbiol ; 60(1): e0161021, 2022 01 19.
Article en En | MEDLINE | ID: mdl-34705536

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pseudomonas aeruginosa / Antibacterianos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Pseudomonas aeruginosa / Antibacterianos Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Año: 2022 Tipo del documento: Article